Elanco Animal Health (ELAN) vs Zoetis (ZTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Elanco Animal Health (ELAN) has outperformed Zoetis (ZTS) over the past year, gaining 14.2% versus a loss of 47.8%. Over five years, ELAN leads with a -29.6% price change compared with -63.0% for ZTS. Zoetis is the larger company by market cap ($30.91 billion vs $11.45 billion), about 2.7 times the size, while Elanco Animal Health is growing revenue faster (+6.2% vs +2.3%).
On valuation, Zoetis trades at a lower forward P/E (11.4x vs 17.8x for Elanco Animal Health). Zoetis pays a dividend yielding 2.75%, while Elanco Animal Health does not currently pay one. Zoetis converts more of its revenue into profit, with a net margin of 28.2% versus -4.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELAN | ZTS |
|---|---|---|
| Share price | $22.92 | $74.81 |
| Market cap | $11.45B | $30.91B |
| 1-day change | +1.69% | +2.37% |
| YTD return | +1.28% | -40.54% |
| 1-year return | +14.20% | -47.83% |
| 5-year return | -29.56% | -63.01% |
| P/E ratio (TTM) | — | 12.03 |
| Forward P/E | 17.84 | 11.43 |
| EPS (TTM) | $-0.41 | $6.22 |
| Dividend yield | 0.00% | 2.75% |
| Annual dividend | $0.00 | $2.06 |
| Revenue (latest FY) | $4.71B | $9.47B |
| Revenue growth (YoY) | +6.22% | +2.28% |
| Net income (latest FY) | $-232.00M | $2.67B |
| Gross margin | 54.99% | 71.84% |
| Net margin | -4.92% | 28.23% |
| 52-week high | $27.98 | $148.30 |
| 52-week low | $19.40 | $68.77 |
| Distance from 52-week high | -18.08% | -49.55% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +35.25% | +28.33% |
| Average volume | 6.17M | 5.42M |
| Shares outstanding | 499.45M | 413.22M |
| Employees | 9,400 | 14,500 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Zoetis is about 2.7 times larger than Elanco Animal Health by market value ($30.91B vs $11.45B).
- ELAN has outperformed ZTS by 62.0 percentage points over the past year.
- Zoetis offers a meaningfully higher dividend yield (2.75% vs 0.00%).
- Zoetis is more profitable, keeping 28.2 cents of every revenue dollar as net income versus -4.9 cents for Elanco Animal Health.
About Elanco Animal Health
ELAN stock →Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark.
Health Care · Biotechnology: Pharmaceutical Preparations · 9,400 employees
About Zoetis
ZTS stock →Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 14,500 employees
ELAN vs ZTS FAQ
Which is bigger, Elanco Animal Health or Zoetis?
Zoetis (ZTS) is larger, with a market capitalization of $30.91B compared with $11.45B for Elanco Animal Health (ELAN).
Which stock has performed better over the past year, ELAN or ZTS?
ELAN returned +14.20% over the past 12 months, compared with -47.83% for ZTS (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Elanco Animal Health or Zoetis?
Zoetis pays a dividend yielding 2.75%, while Elanco Animal Health does not currently pay a regular dividend.
Are Elanco Animal Health and Zoetis in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.